Panoramic Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.11M Hold
116,416
3.92% 8
2026
Q1
$7.52M Sell
116,416
-6,000
-5% -$423K 5.28% 4
2025
Q4
$8.24M Buy
122,416
+32,990
+37% +$2.22M 4.42% 8
2025
Q3
$6.56M Sell
89,426
-574
-0.6% -$38.1K 2.95% 11
2025
Q2
$4.68M Sell
90,000
-45,255
-33% -$2.58M 3.54% 8
2025
Q1
$8.63M Buy
135,255
+80,434
+147% +$4.67M 9.97% 2
2024
Q4
$2.62M Buy
+54,821
New +$2.81M 1.4% 22

Other funds holding HALO

Panoramic Capital's HALO Position: Q2 2026 in Review

Panoramic Capital held its Halozyme (HALO) position steady in Q2 2026 at 116,416 shares worth $9.11M. The position accounts for 3.92% of the portfolio, ranked #8.

Panoramic Capital first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Panoramic Capital held 116,416 shares of Halozyme worth $9.11M as of Q2 2026.
  • Panoramic Capital left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up 3.92% of Panoramic Capital's portfolio in Q2 2026, its #8 holding.
  • Panoramic Capital first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Panoramic Capital's 13F filing for Q2 2026, filed 14 Aug 2026.